Maite
García Fernández de Barrena
Profesional Investigadora
Publicaciones (82) Publicaciones de Maite García Fernández de Barrena
2024
-
Caspases compromise SLU7 and UPF1 stability and NMD activity during hepatocarcinogenesis
JHEP Reports, Vol. 6, Núm. 8
-
Comprehensive in silico CpG methylation analysis in hepatocellular carcinoma identifies tissue- and tumor-type specific marks disconnected from gene expression
Journal of Physiology and Biochemistry
-
Identification of PRMT5 as a therapeutic target in cholangiocarcinoma
Gut
-
KRAS Promotes GLI2-Dependent Transcription during Pancreatic Carcinogenesis
Cancer Research Communications, Vol. 4, Núm. 7, pp. 1677-1689
-
New insights into the regulation of bile acids synthesis during the early stages of liver regeneration: A human and experimental study
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1870, Núm. 5
-
Non-mitogenic FGF19 mRNA-based therapy for the treatment of experimental metabolic dysfunction-associated steatotic liver disease (MASLD)
Clinical science (London, England : 1979), Vol. 138, Núm. 20, pp. 1265-1284
-
Proceedings of the 5th Meeting of Translational Hepatology, organized by the Spanish Association for the Study of the Liver (AEEH)
Gastroenterologia y Hepatologia
-
Sweet dreams could be made of this: carbohydrate-responsive element-binding protein (ChREBP) as a target for hepatocellular carcinoma therapy
Molecular Oncology
2023
-
A new FGF15/19-mediated gut-to-heart axis controls cardiac hypertrophy
Journal of Pathology, Vol. 261, Núm. 3, pp. 335-348
-
Comprehensive analysis of epigenetic and epitranscriptomic genes’ expression in human NAFLD
Journal of Physiology and Biochemistry, Vol. 79, Núm. 4, pp. 901-924
-
Frontiers in fatty liver: recent advances in pathogenic mechanisms, assessment of patients’ prognosis and pharmacotherapy: MASLD: new pathogenic mechanisms, risk assessment tools and drug therapies
Journal of Physiology and Biochemistry
-
Identification and experimental validation of druggable epigenetic targets in hepatoblastoma
Journal of Hepatology, Vol. 79, Núm. 4, pp. 989-1005
-
Loss of liver function in chronic liver disease: An identity crisis
Journal of Hepatology, Vol. 78, Núm. 2, pp. 401-414
-
Mapping early serum proteome signatures of liver regeneration in living donor liver transplant cases
BioFactors, Vol. 49, Núm. 4, pp. 912-927
2022
-
Activation of the unfolded protein response (Upr) is associated with cholangiocellular injury, fibrosis and carcinogenesis in an experimental model of fibropolycystic liver disease
Cancers, Vol. 14, Núm. 1
-
DNA Methylation Regulates a Set of Long Non-Coding RNAs Compromising Hepatic Identity during Hepatocarcinogenesis
Cancers, Vol. 14, Núm. 9
-
Epigenetic remodelling in human hepatocellular carcinoma
Journal of Experimental and Clinical Cancer Research, Vol. 41, Núm. 1
-
Hepatic progenitor cells, senescence and IL-6 as the main players in combined hepatocellular-cholangiocarcinoma development
Journal of Hepatology
-
Impact of CYLD on chromatin structure and histone methylation in malignant melanoma
International Journal of Molecular Medicine, Vol. 49, Núm. 5
-
Metabolic-associated fatty liver disease: From simple steatosis toward liver cirrhosis and potential complications. Proceedings of the Third Translational Hepatology Meeting, organized by the Spanish Association for the Study of the Liver (AEEH)
Gastroenterologia y Hepatologia, Vol. 45, Núm. 9, pp. 724-734